Mutations in the TTDN1 Gene Are Associated with a Distinct Trichothiodystrophy Phenotype  by Heller, Elizabeth R. et al.
Mutations in the TTDN1 Gene Are Associated with
a Distinct Trichothiodystrophy Phenotype
Elizabeth R. Heller1,2, Sikandar G. Khan1,2, Christiane Kuschal1, Deborah Tamura1, John J. DiGiovanna1 and
Kenneth H. Kraemer1
Trichothiodystrophy (TTD) is a rare multisystem disorder, characterized by sulfur-deficient hair with alternating
dark and light ‘‘tiger tail’’ banding on polarized light microscopy. TTD is caused by mutations in DNA repair/
transcription genes XPD, XPB or TTDA, and in TTDN1, a gene of unknown function. Although most of the TTD
patients are photosensitive, patients with TTDN1mutations were reported to be nonphotosensitive. We followed
a cohort of 36 TTD patients from 2001 to 2013. We describe five patients from four families with defects in the
TTDN1 gene: four had no photosensitivity, and one patient exhibited cutaneous burning. Deep phenotyping of
our cohort revealed differences between the patients with and without TTDN1 mutations. Delayed bone age and
seizure disorders were overrepresented in the TTDN1 group (P¼ 0.009 and P¼ 0.024, respectively), whereas some
characteristic TTD clinical, laboratory, and imaging findings were absent. The three oldest TTDN1 patients
displayed autistic behaviors in contrast to the characteristic friendly, socially interactive personality in the other
patients. DNA sequencing revealed deletion mutations in TTDN1 ranging in size from a single base pair to over
120 kb. These data identify a distinct phenotype relationship in TTD caused by TTDN1 mutations and suggest a
different mechanism of disease.
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INTRODUCTION
Trichothiodystrophy (TTD) is a rare, autosomal recessive
disorder associated with defects in DNA repair/transcription
genes. Diagnostic features include short, brittle, sulfur-defi-
cient hair with a pattern of alternating light and dark ‘‘tiger-
tail’’ bands under polarized light microscopy (Baden et al.,
1976; Price et al., 1980; Liang et al., 2005,2006). Additional
features include photosensitivity in approximately half of these
patients, ichthyosis, developmental delay, short stature,
congenital dysmorphism, maternal pregnancy complications,
collodian membrane at birth, and hematologic, ophthal-
mologic, and skeletal abnormalities. TTD is also asso-
ciated with early mortality; affected patients have a 20-fold
increased risk of death before the age of 10 years (Faghri et al.,
2008).
Causative mutations are found in the DNA repair/transcrip-
tion genes, XPD, XPB, or TTDA (DiGiovanna and Kraemer
2012). TTDN1 (Trichothiodystrophy nonphotosensitive 1;
C7ORF11, MPLKIP), a gene of unknown function, is a cause
of the nonphotosensitive TTD phenotype (Nakabayashi et al.,
2005; Stefanini et al., 2010). Previous reports of TTDN1-
associated TTD have identified several heterogeneous
deletions in the gene, ranging from one base pair to
11–31 kb in size (Nakabayashi et al., 2005; Botta et al.,
2007). Patients reported in the literature have been uni-
formly nonphotosensitive; however, no genotype–phenotype
correlations have been found beyond these observations
(Nakabayashi et al., 2005; Botta et al., 2007).
Our study used deep phenotyping, a comprehensive
analysis of phenotypic abnormalities using a detailed data-
base (Boland et al., 2013), to more precisely describe
a subgroup of patients with this rare genetic disorder.
We sought a genotype–phenotype correlation in order to
gain better insight both into the function of the underlying
gene and the overall pathogenicity of the disorder. This
may also serve as a model for future phenotyping studies,
given burgeoning interest in this methodology (reviewed
in Robinson 2012). In the following study, we report five
additional TTD patients with confirmed defects in TTDN1
from our cohort and suggest that there is a distinct phenotype
in TTDN1 patients.
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RESULTS AND DISCUSSION
Clinical features and mutations in five TTDN1 patients
We evaluated 36 patients with features consistent with TTD at
the National Institutes of Health (NIH; Liang et al., 2005,
2006; Schlucker et al., 2006; Boyle et al., 2008; Moslehi et al.,
2010; Zhou et al., 2010; Brooks et al., 2011; Tamura et al.,
2011, 2012; Zhou et al., 2013; Atkinson et al., 2014). Of the
36 patients enrolled in our protocol, 20 were identified with
mutations in XPD, three with TTDA mutations, eight with
unknown mutations, and five with mutations in TTDN1. The
TTDN1 patients ranged in age from 1 to 14 years at the last
NIH evaluation, and came from four different families (Figures
1a–f). Two patients (TTD487BE and TTD488BE) are affected
siblings (Figures 1c and d).
Patient cases and TTDN1 mutations
Patient TTD402BE, a Caucasian male (Figure 1a), was born at
36 weeks of gestation following a pregnancy complicated by
preterm labor. He was hypotonic at birth, but neither
collodian membrane nor cataracts were present. In early
childhood, his scalp hair was sparse and brittle, but it
improved in texture and length by the age of 6 years. He
was mildly photophobic, but his skin did not burn on exposure
to UV. He developed recurrent otitis media, requiring two sets
of pressure equalizing tubes. All developmental milestones
were delayed; he walked at 19 months and continued to
display poor expressive speech and articulation, as well as
intellectual impairment. He was diagnosed with autism
spectrum disorder at the age of 10 years based on repetitive
and obsessive behaviors, poor expressive speech, and diffi-
culty in socialization. At the age of 14 years, he was in the
50th percentile for height and in the 75th percentile for
weight. He exhibited hair findings typical of TTD, includ-
ing coarse, sulfur-deficient hair (sulfur content 2.9%,
normal¼5.0%) with tiger-tail banding on polarized light
microscopy and sparse lateral eyebrows. Minimal facial
freckling, beaked nails, and xerosis (but not ichthyosis) were
noted on skin examination. Other features included high-
arched palate, retrognathia, mild pectus excavatum, mild
genu valgus, pes planus, scoliosis, myopia, nystagmus, and
sialorrhea. Skeletal imaging at the age of 10 years revealed
generalized osteopenia without central osteosclerosis, spina
bifida occulta at C7/T1, and normal bone age. CT bone
densitometry found his average bone mineral density to be
128.7 mg cc1, which is 2.72 standard deviations below age-
matched controls (z-score). A unilateral left kidney was found
on abdominal ultrasound. There was no evidence of dysmye-
lination on brain MRI (magnetic resonance imaging) at the age
of 10 years despite his developmental delay. Blood results
including hemoglobin, hematocrit, mean corpuscular volume,
RBC, neutrophil, and lymphocyte counts, as well as hemo-
globin electrophoresis, were normal. DNA sequencing
of TTD402BE’s cells revealed two different heterozygous
mutations in the initiation codon of TTDN1. The first allele
contained the maternally inherited mutation c.2T4G; a
paternally inherited mutation c.2T4C was identified in the
Figure 1. Characteristics of five TTDN1 patients. All patients have coarse hair with characteristic ‘‘tiger-tail’’ banding and hair shaft abnormalities under polarized
light microscopy. (a) Patient TTD402BE, 14-year-old boy. (b) Patient TTD480BE, 4-year-old girl. (c) Patient TTD487BE, 2-year-old girl. (d) Patient TTD488BE, age 1
(brother of patient TTD487BE). (e) Patient TTD343BE, 14-year-old boy. (f) Alternating light and dark (‘‘tiger-tail’’) banding (red arrow), and hair shaft abnormalities
(black arrow) in TTD402BE under polarized light microscopy. (g and h) Patient TTD343BE is exquisitely sensitive to UV, (g) burning (red arrows) on brief exposure
to an uncovered fluorescent light fixture in an area of the face that was not completely shielded by a hat with brim and sideshield (h) compared with his
appearance before exposure (e). The other TTDN1 patients are nonphotosensitive. Parents of these five patients gave permission to publish these images of their
children and their clinical information.
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second allele (Table 1, Figure 2; Supplementary Figure S1
online). This likely results in the loss of translation initiation
and thus no protein production.
Patient TTD480BE, a Caucasian female (Figure 1b), was
born at term after an uncomplicated pregnancy. The neonatal
period was unremarkable, and the patient did not have low
birth weight, collodian membrane, or congenital cataracts;
feeding difficulties were noted in infancy. She was not
photosensitive. She experienced recurrent otitis media neces-
sitating three sets of pressure equalizing tubes. All develop-
mental milestones were delayed. She walked at the age of
3 years, and at her last NIH visit at the age of 4 years she
spoke few rudimentary words. At this visit, her height and
weight were in the 10th and 5th percentiles, respectively. She
displayed sparse, brittle, sulfur-deficient hair (sulfur content
2.4%, normal¼5.0%) with tiger-tail banding under polarized
light microscopy (Figure 1f), and sparse eyebrows with broken
eyelashes. Skin examination revealed generalized xerosis (not
ichthyosis) with multiple freckle-like macules over the nose
and cheeks, a periumbilical cafe´ au lait spot, and dystrophic,
peeling fingernails and toenails. Other features included
diffuse hypotonia, sialorrhea, strabismus, hyperopia, epi-
canthal folds with mild telecanthus, high nasal bridge, micro-
gnathia, genu valgus, pes planus, and clinodactyly of the right
hand. Imaging showed delayed bone age (estimated age
2 years 3 months) with mild osteopenia, and right-sided aortic
arch with aberrant left subclavian artery. There was no
evidence of dysmyelination on brain MRI. Hemoglobin,
hematocrit, mean corpuscular volume, hemoglobin A2,
RBC, neutrophil, and lymphocyte counts were all normal.
Three years later, she was undergoing evaluation for autism
spectrum disorder owing to new-onset repetitive behaviors
and verbal delay. Array comparative genome hybridization
(aCGH) revealed a 4120 kb deletion in the maternally
inherited allele, resulting in hemizygosity in TTDN1. A single
base pair deletion was found at c.227 in the paternally
inherited TTDN1 allele, leading to a frameshift and stop
codon formation 77 residues downstream (Table 1 and
Figure 2; Supplementary Figure S2 online). It is unlikely that
a functional protein would result from these mutations.
Patients TTD487BE and TTD488BE are Caucasian siblings,
a sister and brother, respectively (Figures 1c and d). They
were each born at term following uncomplicated pregnancies.
Both siblings were nonphotosensitive, mildly hypotonic, and
experienced recurrent upper respiratory infections and otitis
media. They were diagnosed with developmental delay at the
age of 1 year for TTD487BE, and 8 months for TTD488BE.
Cardiac structural defects were found in both siblings—atrial
septal defect in TTD487BE and pulmonic stenosis in
TTD488BE. Atonic seizure disorder was diagnosed in
Table 1. Mutations of all known trichothiodystrophy patients with defects in TTDN1
Allele 1 (maternal) Allele 2 (paternal)
Patient
Photo-
sensitive
Age
(yrs)/sex Genomic mutation
Protein
change
Genomic
mutation
Protein
change References
TTD5PV No 8/F Deletion of 11–31kb No protein Homozygous Fois et al., 1988;
Botta et al., 2007
TTD10RO No 3/M Deletion of at least
150 kb
No protein Homozygous Botta et al., 2007
TTD16PV No 4/F c.148_152delCACAC p.His50Alafs*8 Homozygous Botta et al., 2007
TTD31PV No 3/F c.148_152delCACAC p.His50Alafs*8 c.277delT p.Ser93Profs*60 Botta et al., 2007
TTD1MA No 6/F c.229delC p.Arg77Glyfs*76 Homozygous Botta et al., 2007
TTD11RO No 3/F c.277delT p.Ser93Profs*60 Homozygous Botta et al., 2007
Moroccan Siblings No 16/M; 4/F;
13 months/F
c.187_188delGG 57 residue truncated
protein
Homozygous Przedborski et al., 1990;
Nakabayashi et al., 2005
Amish brittle-hair
brain syndrome
No 20 Amish
patients
c.480A4G p.Met144Val Homozygous Jackson et al., 1974;
Nakabayashi et al., 2005
TTD9PV No 3/F Partial deletion of
exon 1 and entire
exon 2
No protein (probable) Homozygous Rizzo et al., 1992;
Nakabayashi et al., 2005
TTD402BE No 14/M c.2T4C (initiation
codon)
No protein c.2T4G
(initiation
codon)
No protein This paper
TTD480BE No 4/F Deletion of B120kb No protein c.227delG p.Gly76Alafs*77 This paper
TTD487BE
TTD488BE
No 2/F; 1/M c.277delT p.Ser93Profs*60 Deletion of
B92kb
No protein This paper
TTD343BE Yes 14/M 4bp insertion and
deletion of B5 kb
starting at c.279
No protein Homozygous This paper
Bold entries are mutations reported in this article.
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TTD487BE at 2 years of age and in TTD488BE at 18 months.
At NIH, TTD487BE was in the 10th percentile for height and
in the 25th percentile for weight at the age of 2 years, whereas
TTD488BE was in the 97th percentile for height and in the
50th percentile for weight at the age of 1. Both siblings
exhibited characteristic sparse, brittle, and sulfur-deficient hair
(sulfur content 2.6% for TTD487BE and 2.35% for TTD488BE,
normal¼5.0%) with tiger-tail banding under polarized light.
Eyebrows and eyelashes were also sparse. Additional features
for TTD487BE included epicanthal folds with mild tele-
canthus, micrognathia, simplified ears, protruding umbilicus,
bilateral 4th–5th digit clinodactyly with low-placed thumbs,
genu valgus, pes planus, and sialorrhea. Follicular papules
along the extremities and hypoplastic toenails were noted on
her skin examination. TTD488BE displayed left ear crease,
and cyanosis of the bilateral feet in addition to epicanthal
folds, protuberant umbilicus, simplified ears, low-placed
thumbs, and sialorrhea. His skin examination revealed kera-
tosis pilaris and peeling nails, but not ichthyosis. MRI of the
brain did not show evidence of dysmyelination in either
patient. Radiographic studies revealed delayed bone age for
both (estimated age 1 year 6 months for TTD487BE and
newborn for TTD488BE), but no osteosclerosis. Blood work
was normal in both patients, with the exception of a low
neutrophil count in TTD487BE. DNA sequence analysis
revealed a single base deletion at c.277 on the maternally
inherited allele for both siblings, leading to a frameshift and
stop codon formation 60 residues downstream. An aCGH
revealed an approximately 92 kb deletion in the paternally
inherited allele, resulting in hemizygosity in TTDN1 for both
No transcript
Genomic deletion of at least 11 kb
TTD5PV1,2
Genomic deletion of at least 150 kb
TTD10RO1,2
Genomic deletion of at least 120 kb
TTD480BE1
TTD9PV1,2
TTD343BE1,2
c.430A>G
13 Amish patients1,2
c.137_138delGG
3 Moroccan siblings1,2
c.148_152delCACAC
TTD16PV1,2’TTD31PV1
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Figure 2. Mutations in the TTDN1 protein. The 179-amino-acid TTDN1 protein is shown. (Normal protein) glycine/proline-rich regions are colored, with
low-complexity regions shown in blue and purple and highly conserved C-terminal regions (CR1 and CR2) marked. Mutations reported in Nakabayashi et al.,
(2005) and reported in Botta et al., (2007) are shown with standard black lettering, and mutations reported in this paper are in bold blue lettering (Table 1).
The mutations above the normal protein are large deletions (indicated by dashed lines). Mutations below the normal protein are missense (indicated by an arrow)
and one or two base frameshifts followed by an abnormal amino acid sequence (indicated by narrow lines ending at the site of the premature termination codon).
Alleles are denoted by a 1 and/or 2 following the patient identification numbers. Mutation nomenclature and complementary DNA numbering follow
standard formatting (Botta et al., 2007).
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siblings (Table 1 and Figure 2; Supplementary Figure S3
online).
Patient TTD343BE, a Caucasian male (Figures 1e, g and h),
was born at term following an uncomplicated pregnancy.
However, he developed fetal distress during labor and was
delivered via emergency caesarian section. His birth weight
was low (2,450 g). His infancy was remarkable for hypotonia,
difficulty feeding, and failure to thrive. He had a history of
severe photosensitivity, with burning and blistering after brief
exposure to the sun. His mother described that, as an infant, if
his bassinette was placed near a window ‘‘he would scream
and his skin would become raw’’. Consequently, he wore
sunscreen and a hat with visor, neck and ear shields, and
sunscreen even when indoors (Figure 1h). We observed this
exquisite photosensitivity when he began to complain of
discomfort during a brief exposure to an unshielded fluores-
cent light while waiting in a hallway at NIH. Shortly there-
after, he developed a burn in an uncovered area of his face
(Figure 1g). He developed recurrent upper respiratory and
gastrointestinal infections, necessitating multiple hospitaliza-
tions. He did not meet his developmental milestones appro-
priately, walking independently at the age of 4 years and first
speaking at the age of 8 years. At the age of 10 years, he was
diagnosed with autism based on his language delay, repetitive
behaviors, and difficulty in socialization. He consistently grew
at or below the 5th percentile for height and weight; at the
NIH, he waso3rd percentile for both height and weight at the
age of 14 years. He displayed typical hair findings for TTD,
including coarse, sulfur-deficient hair (sulfur content 2.4%,
normal¼5.0%) with tiger-tail banding under polarized light
with few shaft abnormalities. His hair grew long and thick,
which is an unusual finding for TTD patients. His eyebrows
and eyelashes were sparse and broken. Generalized xerosis
and spooned, peeling nails were noted on skin examination.
Additional features included epicanthal folds, prominent nose
tip and high nasal bridge, smooth philtrum, mild micro-
gnathia, retrognathia, pectus excavatum, and genu valgus, as
well as pes planus, bilateral 2nd–3rd toe syndactyly, and
sialorrhea. Imaging revealed delayed bone age (estimated age
12 years 6 months), but no evidence of dysmyelination on
brain MRI. At the age of 24 years, he developed epilepsy with
grand mal seizures. DNA sequencing of TTD343BE revealed
homozygosity for a 4 bp insertion in the TTDN1 gene,
followed by a 5 kb deletion starting at c.279 (Table 1 and
Figure 2; Supplementary Figure S4 online). Both parents were
found to be heterozygous for this mutation. Because the
deletion spans both exons of TTDN1, PCR amplification of
genomic DNA did not yield a band for TTD343BE
(Supplementary Figure S5 online). Bands can be seen for the
four remaining TTDN1 patients, all of whom have at least one
copy of the gene.
No increased sensitivity to UVC in TTDN1 cells
Defects in TTDN1 were believed to be a cause of the
nonphotosensitive TTD phenotype, as no reported cases in
the literature were described to develop cutaneous burning on
sun exposure (Nakabayashi et al., 2005; Botta et al., 2007).
Similarly, four out of five TTDN1 patients in our cohort were
nonphotosensitive; however, one patient (TTD343BE) did
exhibit exquisite photosensitivity. Of the 30 reported cases
of TTDN1 (Table 1), no other patients were noted to be
photosensitive.
We performed UVC hypersensitivity studies on fibroblasts
from each of the four TTDN1 families to measure their cellular
sensitivity to UVC (Figure 3). Fibroblasts from the photosensi-
tive patient, TTD343BE, had a cellular response profile similar
to those of the other, nonphotosensitive, TTDN1 patients and
the normal control. In contrast, fibroblasts from photosensitive
xeroderma pigmentosum (XP) and TTD patients with muta-
tions in XPD showed increased sensitivity to UV (Figure 3;
Boyle et al., 2008). By dissociating cell death from clinical
photosensitivity, this result suggests that cell death is not
required to stimulate inflammatory mediators that result in
cutaneous burning. These findings also provide further
evidence that TTDN1 does not have a role in transcription-
coupled nucleotide excision repair, unlike photosensitive
TTD-associated genes XPD, TTDA, and XPB (Nakabayashi
et al., 2005; Stefanini et al., 2010). The TTDN1 protein has
been reported to interact with Polo-like kinase 1 to help
regulate cell cycle progression (Zhang et al., 2007); however,
this has not been confirmed.
Deep phenotyping reveals a distinct TTDN1 genotype–
phenotype relationship
Our detailed clinical analysis (Supplementary Table S1 online)
of a cohort of 36 patients exhibiting features of TTD uncovered
a distinct genotype–phenotype relationship in patients with
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Figure 3. Post-UV survival of TTDN1, xeroderma pigmentosum (XP), and
normal cell lines. Cell cultures were exposed to the indicated dose of UVC,
and post-UVC viability was assessed after 4 days using an MTS assay. One
normal (FXP0223, open circle), one XP (XP29BE, open diamond), and four
TTDN1 (TTD402BE, closed triangle; TTD480BE, closed circle; TTD487BE,
open triangle; and TTD343BE, open square) cells were used. Overlapping
points were displaced for clarity. Interestingly, fibroblasts from photosensitive
and nonphotosensitive TTDN1 patients were not hypersensitive to UVC in
contrast to cells from an XP patient with mutations in the XPD gene.
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defects in TTDN1. As compared with patients with mutations
in XPD, TTDA, or unidentified genes, delayed bone age and
seizure disorders were overrepresented in the TTDN1 group.
There were three patients from two families with TTDN1
mutations (TTD343BE, and siblings TTD487BE and
TTD488BE) diagnosed with seizure disorders, but only 3 out
of the 31 other TTD patients (P¼ 0.024). In addition, four
patients from three families with TTDN1 defects had delayed
bone age (TTD343BE, TTD480BE, and siblings TTD487BE and
TTD488BE), as compared with 4 out of 23 TTD patients with
other mutations (P¼0.009). These findings are consistent with
earlier case reports (Table 1): seizure disorders were reported
in two separate families with confirmed TTDN1 defects
(Jackson et al., 1974; Przedborski et al., 1990), as was
delayed bone age (Fois et al., 1988; Przedborski et al., 1990).
Our TTDN1 patients had characteristic hair findings of tiger-
tail banding and brittle, sulfur-deficient hair, recurrent infec-
tions, intellectual impairment, hypotonia, and osteopenia, as
seen in TTD. However, other features consistent with
TTD, including pregnancy complications, low birth weight,
collodian membrane at birth, reduced height and weight,
cataracts, thalassemia-like changes on blood work, and
imaging findings of brain dysmyelination (Viprakasit et al.,
2001; Kraemer et al., 2007; Faghri et al., 2008; Tamura et al.,
2011; Brooks et al., 2011; DiGiovanna and Kraemer 2012),
were underrepresented or absent. TTD is also associated
with a strikingly sociable, outgoing, and friendly personality.
In contrast, the three oldest TTDN1 patients within our cohort
(TTD402BE, TTD343BE, and TTD480BE) displayed autistic
features, including repetitive behaviors, obsessive interests,
and difficulty socializing. Similar autistic features in TTD
patients with confirmed TTDN1 defects have been pre-
viously reported in case studies, reinforcing this genotype–
phenotype correlation (Przedborski et al., 1990; Rizzo et al.,
1992). Taken together, the overrepresentation of seizure
disorders, delayed bone age, and autistic features in this
subgroup, as well as the absence of other characteristic TTD
features, represents a distinct phenotype and suggests a
different mechanism of disease for patients with TTDN1
defects.
Eight TTDN1 mutations were associated with a TTD
phenotype in the literature (Table 1 and Figure 2). Seven of
these mutations were deletions, which involved one or two
base pairs, leading to a frameshift followed by a premature
stop codon, or large deletions, preventing protein production.
Most mutations were found in a single patient or family;
however, one cohort of 20 affected individuals of Amish
background was reported with a common homozygous
TTDN1 missense mutation (Jackson et al., 1974). DNA
analysis of our cohort revealed large deletions in TTDN1 in
three families, leading to hemizygosity, a finding consistent
with previous reports (Table 1 and Figure 2). These deletions
would be expected to involve the adjacent SUGCT (succinyl-
CoA:glutarate-CoA transferase) gene on chromosome 7. Muta-
tions in SUGCT have been reported to be associated with
autosomal recessive glutaric aciduria type 3 (Sherman et al.,
2008; Marlaire et al., 2014). However, our TTDN1 patients
had deletions of only one SUGCT allele, and the two patients
tested had normal urinary organic acids. A single base-pair
deletion discovered in one family was also reported in two
unrelated patients in the literature (Botta et al., 2007),
indicating perhaps the location of a mutational hotspot.
Other mutations in TTDN1 were found in two families; we
report compound heterozygous missense mutations in the
initiation codon in one family, and in the second a single
base-pair deletion occurring near a previously reported
mutation. The mutations uncovered in our cohort are
expected to result in a null protein, which suggests that
TTDN1 is not essential for life (Nakabayashi et al., 2005;
Botta et al., 2007), in contrast to other TTD-causing genes that
are part of the basal transcription factor TFIIH (XPB, XPD, and
TTDA; DiGiovanna and Kraemer 2012).
The identification of genotype–phenotype correlations in
complex genetic diseases such as TTD will allow clinicians to
better predict the underlying genetic defect, providing more
timely diagnosis and more specific prognostic information.
This may be especially useful in patients for whom mutations
could not be identified. For example, one previously reported
TTD patient described as having autism, mental retardation,
and seizures was unable to be genotyped (Schepis et al.,
1997). On the basis of additional findings of delayed bone age
and normal laboratory blood values, our findings suggest that
this patient may have had a defect in TTDN1. In the future, we
seek to further clarify genotype–phenotype relationships for
TTD patients with XPD and TTDA mutations using the deep
phenotyping methodology outlined in this study. With the
information we collect, we also hope to identify features that
may predict early mortality in these patients, identify causative
mutations in patients with unknown defects, and further our
understanding of disease pathogenesis in TTD.
MATERIALS AND METHODS
Patients with features consistent with TTD were enrolled in an NCI
Institutional Review Board–approved DNA repair disease natural
history protocol 99-C-0099, which adhered to the Declaration of
Helsinki Protocols. Informed consent was obtained, following which
patients underwent thorough skin examination, skin biopsy for
fibroblast culture, and blood draw for both diagnostic and research
purposes. Diagnostic blood tests for each patient included Chem 20,
hepatic, lipid, mineral, and iron panels, complete blood count with
differential, immunoglobulin A, E, G, and M levels, hemoglobin
electrophoresis, thyroid function tests, vitamin D and vitamin B12
levels, and additional tests according to medical need. Hair samples
were also collected from each patient for examination under
polarized light microscopy (Liang et al., 2005) and amino acid
analysis (Liang et al., 2006). Further assessments included ophthal-
mology (Brooks et al., 2011), audiology, neurology, radiology, and
others, as medically indicated (Atkinson et al., 2014).
Clinical documentation, imaging and laboratory results were
collected and reviewed for all TTD patients using the NIH Clinical
Center Biomedical Translational Research Information System
(BTRIS), in addition to records obtained from outside facilities. We
extracted more than 160 features to build a large clinical database
using Microsoft Excel (Supplementary Table S1 online). These features
were used to compare patients with defects in TTDN1 with those with
other mutations within our cohort. Statistical analysis included
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Fisher’s exact tests. Two-sided P-values were used with a cutoff of
Po0.05.
Clinical protocol, cells, and culture conditions
Skin biopsies were obtained and sent to the Human Genetic Mutant
Cell Repository (Camden, NJ) or Fisher BioServices (NCI Frederick
Central Repository, Frederick, MD) for establishment of fibroblast cell
cultures. Fibroblast cultures from five TTD (TTD402BE, FXP0109;
TTD480BE, FXP0416; TTD487BE, FXP0390; TTD488BE, FXP0388;
TTD343BE, JA1451) and 1 XPD (XP29BE, GM11613) patients and
normal control (FXP0223) were grown in DMEM (Invitrogen, Carls-
bad, CA) containing 4 mM glutamine and 10% fetal calf serum
(Atlanta Biologicals, Flowery Branch, GA) in an 8% CO2 humidified
incubator at 371C, as described previously (Zhou et al., 2013).
Post-UV cell survival
The measurement of cell viability 4 days after UVC exposure was
carried out as described previously using a 3-(4, 5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-4 (-sulfophenyl)-2H-tetrazolium
(MTS; Promega, Madison, WI; Imoto et al., 2002).
PCR amplification and nucleotide sequence analysis
To identify the genetic changes, the entire coding region of the
TTDN1 (C7orf11) gene including splice donor and acceptor sites of
exon 1 and exon 2 were amplified by PCR. The primers were
designed on the basis of GenBank reference sequences (accession
nos. NC_000007 for genomic sequence and NM_138701 for mRNA
sequence). TTDN1 complementary DNA sequences were followed
with numbering based on base 1 as the A of the ATG initiation codon.
The following forward and reverse primer sequences were used to
amplify the entire exon 1 and exon 2 regions of the TTDN1 gene:
exon 1–50-CGAGGTTTTCGGCTTTGGCTC-30, 50-TCTCTAAGCCT-
CAGTTCGCTC-30 (PCR fragment: 510 bp); exon 2–50-ACTTTTAAG-
CAGCAATGTGATTCC-30, 50-GTATTGTTGGCTTATATCCACTAC-30
(PCR fragment: 252 bp). The PCR amplification was achieved using
primer pairs, Advantage GC genomic PCR Kit (Clontech Laboratories,
Mountain View, CA), and patients’ DNA was separated either from
cells or blood. The PCR steps were conducted as follows: 94 1C for
1 minute, then 35 cycles of amplification (94 1C for 20 seconds and
62 1C for 2 minutes), ending with 62 1C for 3 minutes. The PCR
products were resolved on a 2% agarose gel. The PCR bands in the
gel were visualized with EZ-Vision (Amresco, Solon, OH) and UV
light and photographed. After agarose gel purification, the PCR
product was subcloned into pCR2.1-TOPO vector (TOPO TA cloning
kit; Invitrogen) as per the vendor’s protocol in order to separate both
mutant alleles. Mutations were confirmed by nucleotide sequencing.
PCR was used to map the homozygous large deletion in genomic
DNA from patient TTD343BE. The forward primer (50-
TTTTGGTAAAGGACTA-30) in C7orf11 gene and the reverse primer
(50-ATTCACCAAAACTAAT-30) in GRCh38 Primary Assembly
Sequence ID: NC_000007.14 that flanks the deletion gives a 441 bp
PCR product using the Advantage GC genomic PCR Kit (Clontech
Laboratories). The PCR steps were 94 1C for 1 minute, and then 35
cycles of amplification (94 1C for 20 seconds and 52 1C for 2 minutes),
ending with 52 1C for 3 minutes. Sequencing of direct PCR or cloned
PCR products was performed by cycle sequencing using dideoxy
termination chemistry and a Prism Model 3700 Capillary Array
Sequencer using PCR primers (Applied Biosystems, Grand Island,
NY), as described in Zhou et al., (2013). An aCGH was performed by
the National Cancer Institute Clinical Molecular Profiling Core using
a custom-designed high-density DNA repair gene array, as previously
described (Tan et al., 2013).
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